Literature DB >> 17296254

The inhibition of different types of potassium channels underlies the antidepressant-like effect of adenosine in the mouse forced swimming test.

Manuella P Kaster1, Josiane Budni, Ricardo W Binfaré, Adair R S Santos, Ana Lúcia S Rodrigues.   

Abstract

It was previously shown that the acute administration of adenosine elicits an antidepressant-like effect in the mouse forced swimming test (FST) by a mechanism dependent on the inhibition of the L-arginine-nitric oxide (NO)-guanylate cyclase pathway. Taken into account that the stimulation of this pathway is associated with the activation of K(+) channels, this study investigated the involvement of different types of K(+) channels in the effect of adenosine in the FST. Intracerebroventricular treatment of mice with tetraethylammonium (TEA, a non-specific inhibitor of K(+) channels, 25 pg/site), glibenclamide (an ATP-sensitive K(+) channel inhibitor, 0.5 pg/site), charybdotoxin (a large- and intermediate-conductance calcium-activated K(+) channel inhibitor, 25 pg/site) or apamin (a small-conductance calcium-activated K(+) channel inhibitor, 10 pg/site) was able to potentiate the action of subeffective doses of adenosine (1 mg/kg, i.p.) and fluoxetine (a serotonin reuptake inhibitor, 10 mg/kg, i.p.). Furthermore, the administration of adenosine or fluoxetine and the K(+) channel inhibitors, alone or in combination, did not affect the ambulatory behavior. Moreover, the reduction in the immobility time elicited by active doses of adenosine (10 mg/kg, i.p.) or fluoxetine (32 mg/kg, i.p.) in the FST was prevented by the pretreatment of mice with cromakalim (a K(+) channel opener, 10 microg/site, i.c.v.), without affecting the locomotion in an open-field. Together these results indicate that the modulatory effects of adenosine and fluoxetine on neuronal excitability, via inhibition of K(+) channels, may represent the final pathway of their antidepressant-like effects in the FST.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17296254     DOI: 10.1016/j.pnpbp.2006.12.018

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  5 in total

Review 1.  Purinergic system dysfunction in mood disorders: a key target for developing improved therapeutics.

Authors:  Robin Ortiz; Henning Ulrich; Carlos A Zarate; Rodrigo Machado-Vieira
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2014-11-07       Impact factor: 5.067

2.  Evidence for the Involvement of Potassium Channel Inhibition in the Antidepressant-Like Effects of Hesperidin in the Tail Suspension Test in Mice.

Authors:  Franciele Donato; Carlos Borges Filho; Renata Giacomeli; Elza Eliza Tenório Alvater; Lucian Del Fabbro; Michele da Silva Antunes; Marcelo Gomes de Gomes; André Tiago Rossito Goes; Leandro Cattelan Souza; Silvana Peterini Boeira; Cristiano Ricardo Jesse
Journal:  J Med Food       Date:  2015-02-03       Impact factor: 2.786

3.  The antidepressant-like effect of inosine in the FST is associated with both adenosine A1 and A 2A receptors.

Authors:  Manuella P Kaster; Josiane Budni; Marta Gazal; Mauricio P Cunha; Adair R S Santos; Ana Lúcia S Rodrigues
Journal:  Purinergic Signal       Date:  2013-04-25       Impact factor: 3.765

4.  Modulation of Brain Glutathione Reductase and Peroxiredoxin 2 by α-Tocopheryl Phosphate.

Authors:  Mariana Figueiroa Uchoa; Luiz Felipe de Souza; Danubia Bonfanti Dos Santos; Tanara Vieira Peres; Danielle Ferraz Mello; Rodrigo Bainy Leal; Marcelo Farina; Alcir Luiz Dafre
Journal:  Cell Mol Neurobiol       Date:  2016-01-09       Impact factor: 5.046

5.  Synergistic antidepressant-like effect of the joint administration of caffeine and NMDA receptor ligands in the forced swim test in mice.

Authors:  Anna Serefko; Aleksandra Szopa; Aleksandra Wlaź; Sylwia Wośko; Piotr Wlaź; Ewa Poleszak
Journal:  J Neural Transm (Vienna)       Date:  2015-10-28       Impact factor: 3.575

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.